AMC
AMC Entertainment Holdings, Inc.
AMC lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ASST
Strive, Inc.
There isn't enough reported data to score ASST yet.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
ASST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Strong |
ASST's revenue and balance sheet are currently healthy, but its profitability and cash flow are weak.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
ASST PE Valuation
ASST has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 6.0x next year's earnings.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ASST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASST to return to profit, with revenue growing. However, they disagree widely on these estimates.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC has the edge over ASST on earnings, with more consistent year-over-year improvement.
ASST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.73 | — |
| Q3 2026 | -$183.86 | -$41.36 |
| Q2 2026 | -$313.10 | -$286.40 |
| Q1 2026 | -$312.73 | -$277.83 |
| Q4 2025 | -$310.80 | -$242.50 |
| Q3 2025 | -$142.50 | -$78.70 |
| Q2 2025 | -$26.70 | +$37.90 |
| Q1 2025 | -$34.90 | +$28.10 |
| Q4 2024 | -$68.30 | -$32.30 |
ASST lost $183.86 per share over the past year, a bigger loss than the year before.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC's revenue is growing: $1.7B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC's operating margin was 15% last quarter, up 12 points from the same quarter a year ago, near the top of its range since 2019.
ASST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +75% |
| Q2 2026 | $2.9M | +1597% |
| Q1 2026 | $2.8M | +1516% |
| Q4 2025 | $1.5M | +611% |
| Q3 2025 | $1.5M | +660% |
| Q2 2025 | $173.3K | +86% |
| Q1 2025 | $170.7K | +37% |
| Q4 2024 | $212.8K | +163% |
ASST has the edge over AMC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18844% | +20355 points |
| Q2 2026 | -8781% | -7227 points |
| Q1 2026 | -11346% | -10376 points |
| Q4 2025 | -15948% | -15020 points |
| Q3 2025 | -1511% | -863 points |
| Q2 2025 | -1554% | +303 points |
| Q1 2025 | -970% | +141 points |
| Q4 2024 | -928% | +739 points |
ASST has the edge over AMC on profitability, with a higher operating margin.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over ASST on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.1M | +$18.8M |
| Q3 2025 | -$28.9M | -$27.8M |
| Q2 2024 | -$1.3M | -$146.2K |
| Q1 2024 | -$1.1M | -$224.6K |
| Q4 2023 | -$860.1K | -$650.5K |
| Q2 2023 | -$1.1M | -$917.5K |
| Q1 2023 | -$829.9K | -$754.9K |
| Q4 2022 | -$209.6K | -5434% |
ASST has burned cash in almost every quarter: −$75M over the past year, against −$32M the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has the edge over ASST on shareholder dilution, with a more favorable share count trend.
ASST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +20% | +15.3M shares |
| 1 year | +5331% | +88.9M shares |
| 3 years | +65691% | +90.4M shares |
| 5 years | +1478019% | +90.5M shares |
ASST has 91M diluted shares, up 5331% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | $500,000 |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
ASST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -1.7x | Net Cash |
ASST has more cash than debt.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
ASST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 51.4 | Neutral |
ASST's weekly RSI is 51 (neutral) and its Stochastic is 51 (neutral).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
ASST PE vs Communication Services Sector
ASST has no meaningful PE right now: it lost money over the past year.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has stronger trend alignment. AMC is above 4 of 5 weekly averages versus ASST above 2 of 4.
ASST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.8 | 14% below |
| 20 week MA | $20.8 | 7% above |
| 50 week MA | $16.8 | 32% above |
| 100 week MA | $35.7 | 38% below |
ASST's trend is mixed: it's above two of its four weekly moving averages, and 38% below its 100-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over ASST on returns for 2026, with the stronger performance.
ASST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $355.0 | $63.9 | -82% |
| 2024 | $63.9 | $9.32 | -85% |
| 2025 | $9.32 | $16.3 | +75% |
| 2026 YTD | $16.3 | $22.3 | +37% |
ASST is up 37% so far in 2026, after finishing lower in two of the previous three years.